By Professor Pascal Pujol, Oncogeneticist,
Head of the Oncogenetics Department at the University Hospital of Montpellier
President of the French Society of Predictive and Personalized Medicine
During the ESMO (European Society for Medical Oncology) congress held in Madrid from October 19th to 24th, 2023, Professor Pujol offers you a brief summary of the most exciting topics of this fantastic edition.
• Immunotherapy : What's new ?
Expansion of the use of Immunotherapy : MSI testing becomes the most predictive marker of efficacy.
• Role of large NGS panels in the management of cancers of unknown primary "CUP" and rare cancers.
• Non-small cell lung cancers (NSCLC) : Undeniable efficacy of anti-RET drugs justifying systematic research of RET fusions by RNAseq.